Duvuru Geetha

7.3k total citations · 1 hit paper
123 papers, 2.1k citations indexed

About

Duvuru Geetha is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Genetics. According to data from OpenAlex, Duvuru Geetha has authored 123 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Pulmonary and Respiratory Medicine, 49 papers in Nephrology and 36 papers in Genetics. Recurrent topics in Duvuru Geetha's work include Vasculitis and related conditions (89 papers), Renal Diseases and Glomerulopathies (48 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (35 papers). Duvuru Geetha is often cited by papers focused on Vasculitis and related conditions (89 papers), Renal Diseases and Glomerulopathies (48 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (35 papers). Duvuru Geetha collaborates with scholars based in United States, United Kingdom and Austria. Duvuru Geetha's co-authors include J. Ashley Jefferson, Philip Seo, Lorraine C. Racusen, Andreas Kronbichler, Sam Kant, Edward S. Kraus, Fernando C. Fervenza, Ulrich Specks, Jay S. Markowitz and William H. Westra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Duvuru Geetha

111 papers receiving 2.0k citations

Hit Papers

ANCA-Associated Vasculitis: Core Curriculum 2020 2019 2026 2021 2023 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ANCA-Associated Vasculitis: Core Curriculum 2020
    2019 252 citations Duvuru Geetha et al. American Journal of Kidney Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duvuru Geetha United States 24 1.2k 526 459 440 310 123 2.1k
Megan Griffith United Kingdom 19 804 0.7× 419 0.8× 758 1.7× 296 0.7× 123 0.4× 36 1.7k
A. Néel France 25 706 0.6× 112 0.2× 455 1.0× 246 0.6× 268 0.9× 100 2.0k
Cloé Comarmond France 26 1.1k 1.0× 338 0.6× 853 1.9× 209 0.5× 88 0.3× 59 2.5k
Xinping Tian China 27 699 0.6× 268 0.5× 1.6k 3.4× 164 0.4× 152 0.5× 214 2.8k
Andrew Exley United Kingdom 23 1.2k 1.0× 119 0.2× 596 1.3× 296 0.7× 102 0.3× 46 2.3k
Vicente Rodríguez‐Valverde Spain 26 1.2k 1.0× 327 0.6× 2.0k 4.4× 521 1.2× 327 1.1× 67 3.2k
Véronique Le Guern France 29 996 0.8× 597 1.1× 1.9k 4.2× 215 0.5× 84 0.3× 111 3.4k
W. Joseph McCune United States 23 988 0.8× 309 0.6× 1.4k 3.1× 372 0.8× 39 0.1× 41 2.5k
Karen Quillen United States 22 212 0.2× 402 0.8× 334 0.7× 685 1.6× 113 0.4× 86 2.3k
Giles Walters Australia 18 330 0.3× 439 0.8× 334 0.7× 153 0.3× 51 0.2× 49 1.7k

Countries citing papers authored by Duvuru Geetha

Since Specialization
Citations

This map shows the geographic impact of Duvuru Geetha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duvuru Geetha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duvuru Geetha more than expected).

Fields of papers citing papers by Duvuru Geetha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duvuru Geetha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duvuru Geetha. The network helps show where Duvuru Geetha may publish in the future.

Co-authorship network of co-authors of Duvuru Geetha

This figure shows the co-authorship network connecting the top 25 collaborators of Duvuru Geetha. A scholar is included among the top collaborators of Duvuru Geetha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duvuru Geetha. Duvuru Geetha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moura, Marta Casal, Peter A. Merkel, David Jayne, et al.. (2025). Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitis. Nature Reviews Rheumatology. 21(12). 719–736.
2.
Geetha, Duvuru, Thomas Neumann, Alexandre Karras, et al.. (2025). Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamide. RMD Open. 11(4). e005743–e005743.
3.
Kronbichler, Andreas, et al.. (2025). Cardiovascular involvement in ANCA-associated vasculitis. Nephrology Dialysis Transplantation. 40(12). 2256–2267.
4.
Geetha, Duvuru, Christian Pagnoux, Sebastian E. Sattui, et al.. (2025). Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial. Lara D. Veeken. 64(6). 3863–3871. 3 indexed citations
5.
Geara, Abdallah Sassine, et al.. (2025). Avacopan for ANCA-associated vasculitis: Beyond the 52-week treatment course. Clinical Nephrology. 104(5). 338–342. 1 indexed citations
6.
Ivković, Vanja, Duvuru Geetha, Balazs Odler, et al.. (2025). WCN25-1022 LONG-TERM KIDNEY FUNCTION BEYOND 12 MONTHS AND KIDNEY RELAPSE AFTER INITIATION OF TREATMENT FOR ANCA-ASSOCIATED VASCULITIS. Kidney International Reports. 10(2). S617–S618. 1 indexed citations
7.
Odler, Balazs, Regina Riedl, Duvuru Geetha, et al.. (2024). The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial. Kidney International. 107(3). 558–567. 3 indexed citations
8.
Ivković, Vanja, Martin Windpessl, İlay Berke, et al.. (2024). ANCA-Associated Glomerulonephritis: Diagnosis and Therapy Proceedings of the Henry Shavelle Lectureship. SHILAP Revista de lepidopterología. 5(1). 26–47. 1 indexed citations
9.
Odler, Balazs, Annette Bruchfeld, Jennifer Scott, et al.. (2023). Challenges of defining renal response in ANCA-associated vasculitis: call to action?. Clinical Kidney Journal. 16(6). 965–975. 5 indexed citations
10.
Odler, Balazs, Regina Riedl, Philipp Gauckler, et al.. (2023). Risk factors for serious infections in ANCA-associated vasculitis. Annals of the Rheumatic Diseases. 82(5). 681–687. 31 indexed citations
11.
Beck, Laurence H., Isabelle Ayoub, Dawn J. Caster, et al.. (2023). KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases. American Journal of Kidney Diseases. 82(2). 121–175. 16 indexed citations
12.
Kronbichler, Andreas, Ingeborg M. Bajema, Duvuru Geetha, & Marcus D. Säemann. (2022). Novel aspects in the pathophysiology and diagnosis of glomerular diseases. Annals of the Rheumatic Diseases. 82(5). 585–593. 15 indexed citations
13.
Stevens, Kate, Eleni Frangou, Jae Il Shin, et al.. (2022). Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS. Nephrology Dialysis Transplantation. 37(8). 1400–1410. 17 indexed citations
14.
Morris, Adam & Duvuru Geetha. (2020). PEXIVAS challenges current ANCA-associated vasculitis therapy. Nature Reviews Nephrology. 16(7). 373–374. 7 indexed citations
15.
Sethi, Sanjeev, et al.. (2016). Crystal-storing histiocytosis. Kidney International. 89(2). 507–507. 6 indexed citations
16.
17.
Manno, Rebecca, Philip Seo, & Duvuru Geetha. (2015). Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study. BMC Nephrology. 16(1). 88–88. 10 indexed citations
18.
Chen, Teresa K., et al.. (2014). Hematuria duration does not predict kidney function at 1 year in ANCA-associated glomerulonephritis. Seminars in Arthritis and Rheumatism. 44(2). 198–201. 13 indexed citations
19.
Geetha, Duvuru, Caroline J. Poulton, Yichun Hu, et al.. (2013). Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans. Seminars in Arthritis and Rheumatism. 43(6). 778–783. 9 indexed citations
20.
Geetha, Duvuru, Betty Tong, Lorraine C. Racusen, Jay S. Markowitz, & William H. Westra. (2002). Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation. 73(12). 1933–1936. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megan Griffith Breakdown of academic impact, for papers by A. Néel Breakdown of academic impact, for papers by Cloé Comarmond Breakdown of academic impact, for papers by Xinping Tian Breakdown of academic impact, for papers by Andrew Exley Breakdown of academic impact, for papers by Vicente Rodríguez‐Valverde Breakdown of academic impact, for papers by Véronique Le Guern Breakdown of academic impact, for papers by W. Joseph McCune Breakdown of academic impact, for papers by Karen Quillen Breakdown of academic impact, for papers by Giles Walters
Rankless by CCL
2026